[Antiarrhythmic action of penbutolol].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D002082:Butylamines / Q000627:therapeutic use; D002725:Chloroform / Q000008:administration & dosage; D003331:Coronary Vessels; D003517:Cyclopentanes / Q000627:therapeutic use; D004285:Dogs; D004837:Epinephrine / Q000008:administration & dosage; D007511:Ischemia; D008026:Ligation; D051379:Mice; D010042:Ouabain / Q000008:administration & dosage; D011412:Propanolamines / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D002082:Butylamines; D003517:Cyclopentanes; D011412:Propanolamines; D010042:Ouabain; D002725:Chloroform; D011433:Propranolol; D004837:Epinephrine
Effects anti-arythmisants du penbutolol